Cns Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $6 | $0 |
Gross Profit | ||||
EBITDA | -5,602 | -2,525 | -3,537 | |
EBIT | -5,603 | -2,526 | -3,538 | |
Net Income | -5,605 | -2,530 | -3,544 | -5,375 |
Net Change In Cash | 0 | 0 | 6 | 0 |
Free Cash Flow | -6,799 | -1,650 | -3,192 | -2,538 |
Cash | 6,973 | 1,491 | 815 | 548 |
Basic Shares | 22,180 | 48,764 | 62,056 | 124 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -4 | -11 | -13 | -11 |
EBITDA | -18,860 | -15,255 | -14,472 | -9,443 |
EBIT | -18,865 | -15,267 | -14,485 | -9,454 |
Net Income | -18,851 | -15,274 | -14,495 | -9,457 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | 6,798 | |||
Free Cash Flow | -14,143 | -10,562 | -13,544 | -7,335 |
Cash | 548 | 10,055 | 5,004 | 14,039 |
Basic Shares | 75 | 27,235 | 17,569 | 11,079 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.25 |
2024-06-30 | -$6.71 |
2024-03-31 | -$0.40 |
2023-12-31 | -$47.70 |
